BlackRock Virginia Municipal Bond Trust (BHV) Stock Price

11.2614 ▲ +0.0114 (+0.10%)
Open: 11.25 Vol: 2.12K Day's range: 11.25 - 11.5506 Oct 16, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BHV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 11.54▼ 11.54▼ 11.54▼ 11.38▼ 11.91▼
MA10 11.64▼ 11.64▼ 11.64▼ 11.46▼ 12.24▼
MA20 11.62▼ 11.69▼ 11.77▼ 11.78▼ 12.39▼
MA50 12.37▼ 12.34▼ 12.37▼ 12.27▼ 11.48▼
MA100 12.53▼ 12.35▼ 12.27▼ 12.33▼ 11.08▲
MA200 11.84▼ 11.58▼ 11.54▼ 11.55▼ 10.95▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.034▲ 0.025▲ 0.011▲ -0.020▼ -0.202▼
RSI 41.728▼ 41.935▼ 41.179▼ 38.808▼ 38.061▼
STOCH 37.305     42.754     42.754     39.900     17.847▼
WILL %R -37.019     -37.019     -37.019     -61.472     -83.626▼
CCI -25.034     -13.063     -16.357     -53.899     -182.279▼
Latest Filters Detected On BHV
CDL $BHV Doji Candlestick Pattern Detected Set Alert
BlackRock Virginia Municipal Bond Trust News
Biohaven Enters Strategic Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions, Lead Candidate BHV-1300 in Phase 3 for Graves ...
Thursday, October 08, 2026 01:01 AM
Ono will obtain an exclusive license to develop and commercialize Biohaven's MoDE pan IgG degraders in Japan, South Korea, Taiwan, and ASEAN member states, led by BHV-1300 and including certain ...
Biohaven signs Ono deal worth up to $100 million
Wednesday, October 07, 2026 10:26 PM
Biohaven signed an IgG degrader licensing agreement with Ono Pharmaceutical, securing $80 million upfront and up to $100 million in near-term.
Biohaven's Clinical Data on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload, Selected for Oral Presentation at the EORTC-NCI-AACR ...
Monday, September 28, 2026 05:30 AM
Anti-PD-1 combination now enrolling: Under its clinical supply agreement with Regeneron Pharmaceuticals, Inc., Biohaven has begun enrollment, evaluating BHV-1530 in combination with cemiplimab ...
BHV historical stock data
date open high low close volume
16/10/26 11.25 11.5506 11.25 11.2614 2,121
15/10/26 11.25 11.25 11.25 11.25 421
14/10/26 11.5499 11.5499 11.4399 11.475 5,409
13/10/26 11.45 11.45 11.45 11.45 634
12/10/26 11.21 11.45 11.21 11.45 2,983
09/10/26 11.11 11.60 11.11 11.57 1,341
08/10/26 11.45 11.6999 11.45 11.55 2,397
07/10/26 11.3548 11.3548 11.3548 11.3548 367
06/10/26 11.675 11.9099 11.60 11.60 1,977
05/10/26 11.60 11.60 11.60 11.60 2,035
Quote Details
52wk Low:10.04
52wk High:15.15
Vol:2.12K
Avg Vol(3m):77K
1Y Chng:+1.91%
1M Chng:-9.69%
Add to Watch List
More Information
Index N/A
Market Cap. 18.23M